Device / Technology News

RSS

Study shows feasibility of combined postprandial glucose and triglyceride tolerance testing

The Homburg Cream and Sugar (HCS) study was designed to determine whether the measurement of postprandial triglyceride in addition to the assessment of glucose tolerance and traditional risk factors might improve the prediction of cardiovascular events.

29 Aug 2011

European infusion therapy device market to reach €533 million by 2017: New report

According to a new report by iData Research, the leading global authority in medical device market research, the European infusion therapy device market, which includes needleless connectors, infusion pumps and intravenous (IV) sets, was valued at an estimated €443 million in 2010.

29 Aug 2011

Allscripts launches 2011 ACE annual conference

Allscripts today launched its annual conference, the Allscripts Client Experience (ACE), with over 450 educational sessions for more than 4,700 attendees representing care providers in all settings, sizes and specialties.

29 Aug 2011

ConversePoint plans to develop, commercialize next generation clinician communications

ConversePoint, a privately owned company based in Chicago, has announced its plans to develop and commercialize a communications platform for the healthcare industry that will significantly save clinicians time, hospitals millions in productivity costs and improve accountability measurements for critical events per the Joint Commission's National Patient Safety Goals along with the license of key Qualcomm technology.

29 Aug 2011

PREVENT licenses Amorfix's ProMIS to develop vaccines against misfolded prion diseases

The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a national Centre of Excellence for Commercialization and Research (CECR), has signed an exclusive license with Amorfix Life Sciences Ltd. of Missisauga, Ontario for the use of their proprietary ProMIS technology in developing vaccines (active immunotherapy) for the treatment of diseases caused by the formation of misfolded prion.

29 Aug 2011

Cederquist Medical Wellness Center now offers state-of-the-art genetic testing

Cederquist Medical Wellness Center is now offering genetic testing which demonstrates how genetics influence a wide variety of behaviors relating to diet and weight control.

29 Aug 2011

Philips to launch first sleep apnea mobile app at ESC 2011 congress

Royal Philips Electronics will provide clinicians from across the globe with a glimpse of future innovations designed to advance cardiac care, including the current management of cardiovascular disease (CVD) and associated cardiac conditions, during the 2011 Congress of the European Society of Cardiology (ESC), which opens today in Paris.

From Philips Healthcare 29 Aug 2011

New whitepaper about RTLS location accuracy and its impact on hospital ROI

TeleTracking Technologies, Inc. in association with its real-time locating system division, TeleTracking RTLS, today released a white paper underscoring the top 10 reasons why RTLS location accuracy in healthcare matters.

29 Aug 2011

Medicomp releases updated version of MEDCIN Engine

Today, Medicomp Systems announced the first-time distribution of ICD-10-CM mappings and functionality with its new version of the powerful MEDCIN Engine.

29 Aug 2011

FDA clears Toshiba's HDR-08A Imaging System for Kalare

To enhance workflow in today's fast-paced healthcare environment, Toshiba America Medical Systems, Inc. announces the FDA-cleared HDR-08A Imaging System for Kalare, which offers Toshiba's same feature-rich Kalare R&F technology with a new innovative user interface and more advanced image processing.

29 Aug 2011

Neurotechnology's SentiSight 3.0 SDK now available for universal object recognition

Neurotechnology, a provider of high-precision biometric and object identification technologies, today announced the availability of SentiSight 3.0, a Software Development Kit (SDK) for universal object recognition.

29 Aug 2011

Health Endeavors releases web-based ACO Audit Program

Health Endeavors releases web-based ACO Audit Program to assist healthcare providers in achieving PQRS quality measures and ACO success.

29 Aug 2011

Elsevier, Pharmaron sign multi-year contract for Reaxys

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that Pharmaron, a premier drug R&D service provider for the pharmaceutical and biotech industry, has signed a multi-year contract with Elsevier, which will provide unlimited Reaxys access to all Pharmaron researchers.

29 Aug 2011

AF AWARE campaign launches Atrial Fibrillation in Primary Care tool

The AF AWARE campaign today, at the European Society of Cardiology (ESC) Congress 2011 in Paris, announces the launch of the Atrial Fibrillation in Primary Care (AFIP) tool, developed to help primary care physicians (PCPs) with early diagnosis and optimal management of patients with atrial fibrillation.

29 Aug 2011

Everolimus-eluting stent and SES are equally effective for PCI patients

The second generation drug-eluting stent, everolimus-eluting stent (EES), has consistently demonstrated superior clinical outcomes in randomised controlled trials over the first generation drug-eluting stent, paclitaxel-eluting stent.

29 Aug 2011

Sutureless method for reconnecting blood vessels

Reconnecting severed blood vessels is mostly done the same way today - with sutures - as it was 100 years ago, when the French surgeon Alexis Carrel won a Nobel Prize for advancing the technique.

29 Aug 2011

Medical engineers develop sensor chip to monitor cancerous tumors

A surgery is usually one of the first therapy options in cancer treatment. However, some tumors, such as brain tumors, can be difficult to operate on if there is a risk of damaging surrounding nerve tissue.

29 Aug 2011

Vexim receives CE Mark approval for 6.5 mm diameter SpineJack implant

Vexim, the specialist in minimally invasive anatomical restoration of vertebral compression fractures, today announced the CE Marking and the market launch of its 6.5 mm diameter SpineJack implant, which thus guarantees the technology's compliance and safety.

29 Aug 2011

Pfizer's Xalkori receives FDA approval to treat late-stage NSCLC patients with abnormal ALK gene

The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene.

29 Aug 2011

MitraClip treatment could benefit heart failure patients who are unresponsive to CRT

Results of an observational study presented at the European Society of Cardiology (ESC) meeting today in Paris demonstrate that the percutaneous catheter-based MitraClip treatment improves symptoms and promotes reverse left ventricular (LV) remodeling in patients with mitral regurgitation (MR), who do not respond to cardiac resynchronization therapy.

29 Aug 2011